Einsatz neuer Substanzen in der Schwangerschaft

Pharmacology, Toxicology and Pharmaceutical Science

• Breast Cancer 100%
• Lapatinib 25%
• Obstruction 25%
• Protein Tyrosine Kinase Inhibitor 25%
• Receptor 25%
• Side Effect 50%
• Thalidomide 50%
• Trastuzumab 50%

Medicine and Dentistry

• Bevacizumab 25%
• Breast Cancer 100%
• Obstruction 25%
• Oligohydramnios 25%
• Receptor 25%
• Side Effect 50%
• Trastuzumab 50%
• Tyrosine-Kinase Inhibitor 25%

Biochemistry, Genetics and Molecular Biology

• Bevacizumab 50%
• Lapatinib 50%
• Trastuzumab 100%
• Tyrosine Kinase Inhibitor 50%